|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.820 CAD | +0.90% |
|
-7.13% | -17.42% |
| 03-09 | Niagara Region to Deploy Vitalhub's Novari Health Referral Management Technology | MT |
| 03-09 | VitalHub Brief: Announcing Novari Health AI-Enhanced Referral Management Deployment | MT |
| Capitalization | 494M 361M 315M 285M 272M 33.35B 513M 3.39B 1.35B 15.96B 1.36B 1.33B 57.56B | P/E ratio 2025 * |
122x | P/E ratio 2026 * | 31.3x |
|---|---|---|---|---|---|
| Enterprise value | 494M 361M 315M 285M 272M 33.35B 513M 3.39B 1.35B 15.96B 1.36B 1.33B 57.56B | EV / Sales 2025 * |
4.58x | EV / Sales 2026 * | 3.81x |
| Free-Float |
76.89% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Vitalhub Corp.
| 1 day | +0.90% | ||
| 1 week | -7.13% | ||
| Current month | -4.40% | ||
| 1 month | -2.13% | ||
| 3 months | -10.83% | ||
| 6 months | -29.17% | ||
| Current year | -17.42% |
| 1 week | 7.6 |  | 8.36 |
| 1 month | 7.6 | | 8.7 |
| Current year | 7.6 | | 9.72 |
| 1 year | 7.6 | | 14.64 |
| 3 years | 2.35 | | 14.64 |
| 5 years | 2.19 | | 14.64 |
| 10 years | 0.8 | | 14.64 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel Matlow
CEO | Chief Executive Officer | 64 | 27/11/2016 |
Brian Goffenberg
DFI | Director of Finance/CFO | 66 | 27/11/2016 |
Patrick Mazza
COO | Chief Operating Officer | - | 31/05/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Matlow
BRD | Director/Board Member | 64 | 27/11/2016 |
Barry Tissenbaum
BRD | Director/Board Member | 79 | 27/11/2016 |
Roger Dent
BRD | Director/Board Member | - | 31/08/2015 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.90% | -7.13% | -11.64% | +210.32% | 361M | |
| +3.58% | -5.26% | -20.84% | +5.40% | 30.46B | |
| -2.69% | -8.29% | -45.42% | +98.19% | 9.69B | |
| -2.23% | +1.43% | -8.92% | +46.85% | 4.79B | |
| +8.30% | +24.85% | - | - | 3.08B | |
| +2.39% | -9.49% | - | - | 1.79B | |
| -8.56% | -1.73% | - | - | 1.52B | |
| -0.32% | -13.91% | +3.91% | -39.81% | 1.56B | |
| +0.40% | -4.42% | -47.43% | - | 1.16B | |
| +1.41% | -0.98% | -31.94% | -48.83% | 1.13B | |
| Average | +0.32% | -1.69% | -23.18% | +45.35% | 5.55B | |
| Weighted average by Cap. | +1.64% | -2.07% | -24.56% | +27.08% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 108M 78.93M 68.75M 62.25M 59.39M 7.29B 112M 740M 294M 3.49B 296M 290M 12.57B | 130M 94.83M 82.6M 74.79M 71.35M 8.75B 135M 889M 353M 4.19B 356M 348M 15.11B |
| Net income | 3.92M 2.86M 2.49M 2.26M 2.15M 264M 4.06M 26.84M 10.67M 127M 10.75M 10.52M 456M | 16.46M 12.03M 10.48M 9.49M 9.05M 1.11B 17.07M 113M 44.8M 531M 45.14M 44.19M 1.92B |
| Net Debt | - | -156.19 -114.12 -99.4 -90 -85.86 -10.54K -161.94 -1.07K -424.98 -5.04K -428.28 -419.23 -18.18K |
Employees
500
Calendar
03-18 -
Earnings release - Q4 2025
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/03/26 | 7.820 $ | +0.90% | 146,214 |
| 13/03/26 | 7.750 $ | -4.32% | 590,978 |
| 12/03/26 | 8.100 $ | -2.64% | 314,310 |
| 11/03/26 | 8.320 $ | +0.12% | 145,107 |
| 10/03/26 | 8.310 $ | -1.31% | 160,569 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
7.820CAD
Average target price
13.97CAD
Spread / Average Target
+78.67%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- VHI Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition